{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T20:51:28Z","timestamp":1792011088463,"version":"4.4.0"},"reference-count":160,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T00:00:00Z","timestamp":1774483200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001826","name":"Netherlands Organisation for Health Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016230","name":"Steven & Alexandra Cohen Foundation Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016230","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006396","name":"Alexion Pharmaceuticals Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006396","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001833","name":"VU Amsterdam","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001833","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["466168337"],"award-info":[{"award-number":["466168337"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["466168626"],"award-info":[{"award-number":["466168626"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["390873048"],"award-info":[{"award-number":["390873048"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004334","name":"Merck & Co Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013865","name":"Charit\u00e9 Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004176","name":"Miltenyi Biotec","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004176","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004326","name":"Bayer AG","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004326","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003542","name":"Ministerium fur Wissenschaft Forschung und Kunst Baden-Wurttemberg","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003542","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002946","name":"German Aerospace Centre DLR","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002946","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003107","name":"BMG","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003107","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005036","name":"University of Bergen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005036","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016986","name":"Nippon Zenyaku Kogyo Co Ltd","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016986","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004257","name":"Helse Vest RHF","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004257","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009382","name":"Solve ME CFS Initiative","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009382","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014480","name":"Horizon Pharmaceuticals Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014480","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Forschung, Technologie und Raumfahrt","doi-asserted-by":"publisher","award":["01EJ2204D"],"award-info":[{"award-number":["01EJ2204D"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003180","name":"AMC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003180","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001981","name":"ME Research UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001981","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.autrev.2026.104043","type":"journal-article","created":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T01:12:16Z","timestamp":1774487536000},"page":"104043","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Expert perspectives on Myalgic encephalomyelitis\/chronic fatigue syndrome \u2013 Insights from the 3rd International Conference of the Charit\u00e9 Fatigue Center"],"prefix":"10.1016","volume":"25","author":[{"given":"Annick","family":"Fehrer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lara","family":"Windzio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Schoening","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Steiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna C.","family":"Aschenbrenner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Babel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uta","family":"Behrends","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Bellmann-Strobl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Camm\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Cash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfram","family":"Doehner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeroen","family":"den Dunnen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d8ystein","family":"Fluge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christiana","family":"Franke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn","family":"Hoffmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Kedor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wiebke","family":"L\u00f6hden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olav","family":"Mella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenz L.","family":"Mihatsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Peluso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Puta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Putrino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anuradha","family":"Ramoji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wakiro","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgit","family":"Sawitzki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg","family":"Schlieper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yehuda","family":"Schoenfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Seifert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fridbj\u00f6rn","family":"Sigurdsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anouk","family":"Slaghekke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristian","family":"Sommerfelt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franziska","family":"Sotzny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Stein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juergen M.","family":"Steinacker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Stingl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Systrom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl J.","family":"Tronstad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Wirth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhard","family":"W\u00f6rmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rob C.I.","family":"W\u00fcst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Yamamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Scheibenbogen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.autrev.2026.104043_bb0005","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s12967-020-02269-0","article-title":"Systematic review and meta-analysis of the prevalence of chronic fatigue syndrome\/myalgic encephalomyelitis (CFS\/ME)","volume":"18","author":"Lim","year":"2020","journal-title":"J Transl Med"},{"issue":"1","key":"10.1016\/j.autrev.2026.104043_bb0010","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/1741-7015-9-91","article-title":"Prevalence of myalgic encephalomyelitis\/chronic fatigue syndrome (ME\/CFS) in three regions of England: a repeated cross-sectional study in primary care","volume":"9","author":"Nacul","year":"2011","journal-title":"BMC Med"},{"issue":"5","key":"10.1016\/j.autrev.2026.104043_bb0015","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1007\/s11606-024-09290-9","article-title":"Incidence and prevalence of post-COVID-19 Myalgic encephalomyelitis: a report from the observational RECOVER-adult study","volume":"40","author":"Vernon","year":"2025","journal-title":"J Gen Intern Med"},{"issue":"1","key":"10.1016\/j.autrev.2026.104043_bb0020","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3390\/medicina57010007","article-title":"A literature review of GP knowledge and understanding of ME\/CFS: a report from the Socioeconomic Working Group of the European Network on ME\/CFS (EUROMENE)","volume":"57","author":"Pheby","year":"2021","journal-title":"Medicina"},{"issue":"7","key":"10.1016\/j.autrev.2026.104043_bb0025","article-title":"Medical care situation of people with Myalgic encephalomyelitis\/chronic fatigue syndrome in Germany","volume":"57","author":"Froehlich","year":"2021","journal-title":"Medicina (Kaunas)"},{"issue":"5","key":"10.1016\/j.autrev.2026.104043_bb0030","article-title":"European network on Myalgic encephalomyelitis\/chronic fatigue syndrome (EUROMENE): expert consensus on the diagnosis, service provision, and care of people with ME\/CFS in Europe","volume":"57","author":"Nacul","year":"2021","journal-title":"Medicina (Kaunas)"},{"issue":"1","key":"10.1016\/j.autrev.2026.104043_bb0035","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1004511","article-title":"Persistent symptoms and clinical findings in adults with post-acute sequelae of COVID-19\/post-COVID-19 syndrome in the second year after acute infection: a population-based, nested case-control study","volume":"22","author":"Peter","year":"2025","journal-title":"PLoS Med"},{"key":"10.1016\/j.autrev.2026.104043_bb0040","series-title":"The National Academies Collection: Reports funded by National Institutes of Health","article-title":"Beyond Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome: redefining an illness","author":"Committee on the Diagnostic Criteria for Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome, Board on the Health of Select Populations, and Institute of Medicine","year":"2015"},{"issue":"5","key":"10.1016\/j.autrev.2026.104043_bb0045","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1038\/s41591-022-01810-6","article-title":"Unexplained post-acute infection syndromes","volume":"28","author":"Choutka","year":"2022","journal-title":"Nat Med"},{"issue":"11","key":"10.1016\/j.autrev.2026.104043_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2023.103452","article-title":"Understanding, diagnosing, and treating Myalgic encephalomyelitis\/chronic fatigue syndrome - state of the art: report of the 2nd international meeting at the Charit\u00e9 Fatigue Center","volume":"22","author":"Steiner","year":"2023","journal-title":"Autoimmun Rev"},{"issue":"6","key":"10.1016\/j.autrev.2026.104043_bb0055","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1089\/tmj.2020.0339","article-title":"Remote patient monitoring for home management of coronavirus disease 2019 in New York: a cross-sectional observational study","volume":"27","author":"Tabacof","year":"2021","journal-title":"Telemed J E Health"},{"key":"10.1016\/j.autrev.2026.104043_bb0060","article-title":"Post-acute COVID-19 syndrome negatively impacts health and wellbeing despite less severe acute infection","author":"Tabacof","year":"2020","journal-title":"medRxiv"},{"key":"10.1016\/j.autrev.2026.104043_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2021.101019","article-title":"Characterizing long COVID in an international cohort: 7 months of symptoms and their impact","volume":"38","author":"Davis","year":"2021","journal-title":"eClinicalMedicine"},{"issue":"3","key":"10.1016\/j.autrev.2026.104043_bb0070","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/s41579-022-00846-2","article-title":"Long COVID: major findings, mechanisms and recommendations","volume":"21","author":"Davis","year":"2023","journal-title":"Nat Rev Microbiol"},{"issue":"3","key":"10.1016\/j.autrev.2026.104043_bb0075","first-page":"256","article-title":"Vascular pathogenesis in acute and long COVID: current insights and therapeutic outlook","volume":"51","author":"Kruger","year":"2024","journal-title":"Semin Thromb Hemost"},{"issue":"14","key":"10.1016\/j.autrev.2026.104043_bb0080","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1016\/j.cell.2022.06.008","article-title":"Mild respiratory COVID can cause multi-lineage neural cell and myelin dysregulation","volume":"185","author":"Fern\u00e1ndez-Casta\u00f1eda","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.autrev.2026.104043_bb0085","article-title":"A causal link between autoantibodies and neurological symptoms in long COVID","author":"Guedes","year":"2024","journal-title":"medRxiv"},{"issue":"10","key":"10.1016\/j.autrev.2026.104043_bb0090","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1038\/s41590-023-01601-2","article-title":"SARS-CoV-2 reservoir in post-acute sequelae of COVID-19 (PASC)","volume":"24","author":"Proal","year":"2023","journal-title":"Nat Immunol"},{"issue":"7985","key":"10.1016\/j.autrev.2026.104043_bb0095","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/s41586-023-06651-y","article-title":"Distinguishing features of long COVID identified through immune profiling","volume":"623","author":"Klein","year":"2023","journal-title":"Nature"},{"issue":"3-4","key":"10.1016\/j.autrev.2026.104043_bb0100","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1080\/17460794.2025.2483122","article-title":"The reactivation of the various types of viruses following COVID-19 infection: a systematic review","volume":"20","author":"Naderi","year":"2025","journal-title":"Future Virol"},{"issue":"1","key":"10.1016\/j.autrev.2026.104043_bb0105","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/s41467-023-44432-3","article-title":"Muscle abnormalities worsen after post-exertional malaise in long COVID","volume":"15","author":"Appelman","year":"2024","journal-title":"Nat Commun"},{"issue":"22","key":"10.1016\/j.autrev.2026.104043_bb0110","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1001\/jama.2023.8823","article-title":"Development of a definition of postacute sequelae of SARS-CoV-2 infection","volume":"329","author":"Thaweethai","year":"2023","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.autrev.2026.104043_bb0115","doi-asserted-by":"crossref","first-page":"5104","DOI":"10.1038\/s41467-022-32507-6","article-title":"A prospective observational study of post-COVID-19 chronic fatigue syndrome following the first pandemic wave in Germany and biomarkers associated with symptom severity","volume":"13","author":"Kedor","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.autrev.2026.104043_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.102146","article-title":"Long-term symptom severity and clinical biomarkers in post-COVID-19\/chronic fatigue syndrome: results from a prospective observational cohort","volume":"63","author":"Legler","year":"2023","journal-title":"EClinicalMedicine"},{"issue":"6","key":"10.1016\/j.autrev.2026.104043_bb0125","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.autrev.2018.01.009","article-title":"Myalgic encephalomyelitis\/chronic fatigue syndrome - evidence for an autoimmune disease","volume":"17","author":"Sotzny","year":"2018","journal-title":"Autoimmun Rev"},{"issue":"16","key":"10.1016\/j.autrev.2026.104043_bb0130","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10163675","article-title":"Autoantibodies to vasoregulative G-Protein-coupled receptors correlate with symptom severity, autonomic dysfunction and disability in Myalgic encephalomyelitis\/chronic fatigue syndrome","volume":"10","author":"Freitag","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.autrev.2026.104043_bb0135","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.981532","article-title":"Dysregulated autoantibodies targeting vaso- and immunoregulatory receptors in Post COVID Syndrome correlate with symptom severity","volume":"13","author":"Sotzny","year":"2022","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.autrev.2026.104043_bb0140","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1038\/s41467-022-28905-5","article-title":"Autoantibodies targeting GPCRs and RAS-related molecules associate with COVID-19 severity","volume":"13","author":"Cabral-Marques","year":"2022","journal-title":"Nat Commun"},{"issue":"11","key":"10.1016\/j.autrev.2026.104043_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2023.103445","article-title":"Severity of neurological Long-COVID symptoms correlates with increased level of autoantibodies targeting vasoregulatory and autonomic nervous system receptors","volume":"22","author":"Seibert","year":"2023","journal-title":"Autoimmun Rev"},{"issue":"5","key":"10.1016\/j.autrev.2026.104043_bb0150","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1111\/jon.13128","article-title":"Free-water-corrected diffusion and adrenergic\/muscarinic antibodies in myalgic encephalomyelitis\/chronic fatigue syndrome","volume":"33","author":"Kimura","year":"2023","journal-title":"J Neuroimaging"},{"issue":"7","key":"10.1016\/j.autrev.2026.104043_bb0155","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.3390\/jcm13072153","article-title":"Impaired hand grip strength correlates with greater disability and symptom severity in post-COVID Myalgic encephalomyelitis\/chronic fatigue syndrome","volume":"13","author":"Paffrath","year":"2024","journal-title":"J Clin Med"},{"issue":"2","key":"10.1016\/j.autrev.2026.104043_bb0160","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.chest.2021.01.082","article-title":"Insights from invasive cardiopulmonary exercise testing of patients with Myalgic encephalomyelitis\/chronic fatigue syndrome","volume":"160","author":"Joseph","year":"2021","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.autrev.2026.104043_bb0165","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.chest.2021.08.010","article-title":"Persistent exertional intolerance after COVID-19: insights from invasive cardiopulmonary exercise testing","volume":"161","author":"Singh","year":"2022","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.autrev.2026.104043_bb0170","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1186\/s12967-022-03616-z","article-title":"Muscle sodium content in patients with Myalgic encephalomyelitis\/chronic fatigue syndrome","volume":"20","author":"Petter","year":"2022","journal-title":"J Transl Med"},{"issue":"1","key":"10.1016\/j.autrev.2026.104043_bb0175","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1186\/s40478-023-01662-2","article-title":"Post-COVID exercise intolerance is associated with capillary alterations and immune dysregulations in skeletal muscles","volume":"11","author":"Aschman","year":"2023","journal-title":"Acta Neuropathol Commun"},{"key":"10.1016\/j.autrev.2026.104043_bb0180","series-title":"The rising cost of long COVID and ME\/CFS in Germany","author":"Daniell","year":"2025"},{"key":"10.1016\/j.autrev.2026.104043_bb0185","author":"Technical University of Munich"},{"issue":"11","key":"10.1016\/j.autrev.2026.104043_bb0190","doi-asserted-by":"crossref","first-page":"3168","DOI":"10.3390\/jcm13113168","article-title":"The German multicenter registry for ME\/CFS (MECFS-R)","volume":"13","author":"Hieber","year":"2024","journal-title":"J Clin Med"},{"issue":"3","key":"10.1016\/j.autrev.2026.104043_bb0195","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1007\/s00431-023-05351-z","article-title":"Pediatric and adult patients with ME\/CFS following COVID-19: a structured approach to diagnosis using the Munich Berlin Symptom Questionnaire (MBSQ)","volume":"183","author":"Peo","year":"2024","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.autrev.2026.104043_bb0200","author":"Medical University of Vienna"},{"issue":"5","key":"10.1016\/j.autrev.2026.104043_bb0205","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s00508-024-02372-y","article-title":"Interdisziplin\u00e4res, kollaboratives D-A-CH Konsensus-Statement zur Diagnostik und Behandlung von Myalgischer Enzephalomyelitis\/Chronischem Fatigue-Syndrom","volume":"136","author":"Hoffmann","year":"2024","journal-title":"Wien Klin Wochenschr"},{"key":"10.1016\/j.autrev.2026.104043_bb0210","article-title":"Care for ME\/CFS - Praxisleitfaden f\u00fcr die Versorgung von ME\/CFS Betroffenen","author":"Hainzl","year":"2024","journal-title":"Zenodo"},{"issue":"6926","key":"10.1016\/j.autrev.2026.104043_bb0215","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/S0140-6736(56)91236-3","article-title":"Clinical findings six years after outbreak of Akureyri disease","volume":"267","author":"Sigurdsson","year":"1956","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.autrev.2026.104043_bb0220","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1093\/oxfordjournals.aje.a119421","article-title":"A disease epidemic in iceland simulating poliomyelitis","volume":"52","author":"Sigurdsson","year":"1950","journal-title":"Am J Epidemiol"},{"issue":"8621","key":"10.1016\/j.autrev.2026.104043_bb0225","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/S0140-6736(88)90255-3","article-title":"Akureyri disease (Myalgic Encephalomyelitis), Forty Years Later","volume":"332","author":"Hyde","year":"1988","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.autrev.2026.104043_bb0230","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/j.1600-0404.1997.tb00259.x","article-title":"Anxiety disorders: a result of long-term chronic fatigue - the psychiatric characteristics of the sufferers of Iceland disease","volume":"96","author":"L\u00edndal","year":"1997","journal-title":"Acta Neurol Scand"},{"issue":"6926","key":"10.1016\/j.autrev.2026.104043_bb0235","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/S0140-6736(56)91252-1","article-title":"A new clinical entity?","volume":"267","year":"1956","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.autrev.2026.104043_bb0240","doi-asserted-by":"crossref","first-page":"3486","DOI":"10.3390\/jcm13123486","article-title":"Assessing functional capacity in Myalgic encephalopathy\/chronic fatigue syndrome: a patient-informed questionnaire","volume":"13","author":"Sommerfelt","year":"2024","journal-title":"J Clin Med"},{"key":"10.1016\/j.autrev.2026.104043_bb0245","author":"German Clinical Trials Register (DRKS)"},{"issue":"6","key":"10.1016\/j.autrev.2026.104043_bb0250","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","article-title":"The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection","volume":"30","author":"Ware","year":"1992","journal-title":"Med Care"},{"issue":"1","key":"10.1016\/j.autrev.2026.104043_bb0255","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s12967-021-02774-w","article-title":"Hand grip strength and fatigability: correlation with clinical parameters and diagnostic suitability in ME\/CFS","volume":"19","author":"J\u00e4kel","year":"2021","journal-title":"J Transl Med"},{"key":"10.1016\/j.autrev.2026.104043_bb0260","author":"German Federal Institute for Drugs and Medical Devices (BfArM)"},{"issue":"3","key":"10.1016\/j.autrev.2026.104043_bb0265","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1093\/brain\/awad377","article-title":"Vortioxetine for the treatment of post-COVID-19 condition: a randomized controlled trial","volume":"147","author":"McIntyre","year":"2024","journal-title":"Brain"},{"key":"10.1016\/j.autrev.2026.104043_bb0270","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2024.116068","article-title":"Impact of vortioxetine on depressive symptoms moderated by symptoms of anxiety in persons with post-COVID-19 condition: a secondary analysis","volume":"339","author":"Le","year":"2024","journal-title":"Psychiatry Res"},{"issue":"5","key":"10.1016\/j.autrev.2026.104043_bb0275","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1007\/s12325-024-02826-9","article-title":"Assessing the effects of metabolic disruption, body mass index and inflammation on depressive symptoms in post-COVID-19 condition: a randomized controlled trial on vortioxetine","volume":"41","author":"Kwan","year":"2024","journal-title":"Adv Ther"},{"issue":"6","key":"10.1016\/j.autrev.2026.104043_bb0280","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.euroneuro.2014.02.010","article-title":"Agomelatine but not melatonin improves fatigue perception: a longitudinal proof-of-concept study","volume":"24","author":"Pardini","year":"2014","journal-title":"Eur Neuropsychopharmacol"},{"issue":"6","key":"10.1016\/j.autrev.2026.104043_bb0285","first-page":"61","article-title":"Antidepressant and anxiolytic efficacy and tolerability of agomelatine in the treatment of depression after COVID-19 in daily clinical practice (non-interventional study TELESPHOR)","volume":"16","author":"Medvedev","year":"2024","journal-title":"Neurol Neuropsych Psychosom"},{"issue":"7","key":"10.1016\/j.autrev.2026.104043_bb0290","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.jacc.2020.12.029","article-title":"Randomized trial of Ivabradine in patients with hyperadrenergic postural orthostatic tachycardia syndrome","volume":"77","author":"Taub Pam","year":"2021","journal-title":"JACC"},{"issue":"3","key":"10.1016\/j.autrev.2026.104043_bb0295","first-page":"162","article-title":"Ivabradine effects on COVID-19-associated postural orthostatic tachycardia syndrome: a single center prospective study","volume":"13","author":"Abdelnabi","year":"2023","journal-title":"Am J Cardiovasc Dis"},{"key":"10.1016\/j.autrev.2026.104043_bb0300","article-title":"Safety and efficacy of low dose naltrexone in a long covid cohort; an interventional pre-post study","volume":"24","author":"O'Kelly","year":"2022","journal-title":"Brain Behav Immun Health"},{"issue":"2","key":"10.1016\/j.autrev.2026.104043_bb0305","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1093\/cid\/ciae159","article-title":"Favorable antiviral effect of metformin on SARS-CoV-2 viral load in a randomized, placebo-controlled clinical trial of COVID-19","volume":"79","author":"Bramante","year":"2024","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.autrev.2026.104043_bb0310","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12041487","article-title":"Severe and very severe Myalgic encephalopathy\/chronic fatigue syndrome ME\/CFS in Norway: symptom burden and access to care","volume":"12","author":"Sommerfelt","year":"2023","journal-title":"J Clin Med"},{"issue":"4","key":"10.1016\/j.autrev.2026.104043_bb0315","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.1365-2796.2011.02428.x","article-title":"Myalgic encephalomyelitis: international consensus criteria","volume":"270","author":"Carruthers","year":"2011","journal-title":"J Intern Med"},{"issue":"5","key":"10.1016\/j.autrev.2026.104043_bb0320","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.chest.2022.04.146","article-title":"Neurovascular dysregulation and acute exercise intolerance in Myalgic encephalomyelitis\/chronic fatigue syndrome: a randomized, Placebo-Controlled trial of pyridostigmine","volume":"162","author":"Joseph","year":"2022","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.autrev.2026.104043_bb0325","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s15010-024-02386-8","article-title":"Towards an understanding of physical activity-induced post-exertional malaise: Insights into microvascular alterations and immunometabolic interactions in post-COVID condition and myalgic encephalomyelitis\/chronic fatigue syndrome","volume":"53","author":"Haunhorst","year":"2025","journal-title":"Infection"},{"issue":"4","key":"10.1016\/j.autrev.2026.104043_bb0330","doi-asserted-by":"crossref","DOI":"10.1002\/pul2.70009","article-title":"The metabolic and physiologic impairments underlying long COVID associated exercise intolerance","volume":"14","author":"Leitner","year":"2024","journal-title":"Pulm Circ"},{"issue":"11","key":"10.1016\/j.autrev.2026.104043_bb0335","article-title":"Red blood cell morphology is associated with altered Hemorheological properties and fatigue in patients with long COVID","volume":"13","author":"Grau","year":"2024","journal-title":"Biol-Basel"},{"issue":"10","key":"10.1016\/j.autrev.2026.104043_bb0340","doi-asserted-by":"crossref","first-page":"3022","DOI":"10.1111\/jcmm.17320","article-title":"Even patients with mild COVID-19 symptoms after SARS-CoV-2 infection show prolonged altered red blood cell morphology and rheological parameters","volume":"26","author":"Grau","year":"2022","journal-title":"J Cell Mol Med"},{"issue":"5","key":"10.1016\/j.autrev.2026.104043_bb0345","article-title":"The results from red cell shape analyses of blood samples from members of Myalgic encephalomyelitis organisations in four countries","volume":"49","author":"Simpson","year":"1997","journal-title":"J Orthomol Med"},{"issue":"708","key":"10.1016\/j.autrev.2026.104043_bb0350","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abq1533","article-title":"Core mitochondrial genes are down-regulated during SARS-CoV-2 infection of rodent and human hosts","volume":"15","author":"Guarnieri","year":"2023","journal-title":"Sci Transl Med"},{"issue":"89","key":"10.1016\/j.autrev.2026.104043_bb0355","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.adi5377","article-title":"Regulatory T cells shield muscle mitochondria frominterferon-\u03b3\u2013mediated damage to promote thebeneficial effects of exercise","volume":"8","author":"Langston","year":"2023","journal-title":"Sci Immunol"},{"key":"10.1016\/j.autrev.2026.104043_bb0360","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1070994","article-title":"A scoping review of regulatory T cell dynamics in convalescent COVID-19 patients - indications for their potential involvement in the development of Long COVID?","volume":"13","author":"Haunhorst","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2026.104043_bb0365","series-title":"Skeletal muscle properties in long COVID and ME\/CFS differ from those induced by bed rest","author":"Charlton","year":"2025"},{"issue":"3","key":"10.1016\/j.autrev.2026.104043_bb0370","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25031675","article-title":"Functional and morphological differences of muscle mitochondria in chronic fatigue syndrome and post-COVID syndrome","volume":"25","author":"Bizjak","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"12","key":"10.1016\/j.autrev.2026.104043_bb0375","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0277984","article-title":"Recovery of performance and persistent symptoms in athletes after COVID-19","volume":"17","author":"Vollrath","year":"2022","journal-title":"PloS One"},{"issue":"1","key":"10.1016\/j.autrev.2026.104043_bb0380","doi-asserted-by":"crossref","DOI":"10.1002\/jcsm.13669","article-title":"Key pathophysiological role of skeletal muscle disturbance in post COVID and Myalgic encephalomyelitis\/chronic fatigue syndrome (ME\/CFS): accumulated evidence","volume":"16","author":"Scheibenbogen","year":"2025","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"1","key":"10.1016\/j.autrev.2026.104043_bb0385","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1152\/ajpendo.00539.2015","article-title":"Na,K-ATPase regulation in skeletal muscle","volume":"311","author":"Pirkmajer","year":"2016","journal-title":"Am J Physiol Endocrinol Metabol"},{"issue":"12","key":"10.1016\/j.autrev.2026.104043_bb0390","doi-asserted-by":"crossref","first-page":"3465","DOI":"10.1016\/j.celrep.2018.11.084","article-title":"Allosteric regulation of NCLX by mitochondrial membrane potential links the metabolic state and Ca2+ signaling in mitochondria","volume":"25","author":"Kostic","year":"2018","journal-title":"Cell Rep"},{"key":"10.1016\/j.autrev.2026.104043_bb0395","article-title":"Autoantibodies to arginine-rich sequences mimicking epstein-barr virus in post-COVID and Myalgic encephalomyelitis\/chronic fatigue syndrome","author":"Hoheisel","year":"2024","journal-title":"medRxiv"},{"issue":"11","key":"10.1016\/j.autrev.2026.104043_bb0400","doi-asserted-by":"crossref","DOI":"10.14814\/phy2.14138","article-title":"Abnormal blood lactate accumulation during repeated exercise testing in myalgic encephalomyelitis\/chronic fatigue syndrome","volume":"7","author":"Lien","year":"2019","journal-title":"Physiol Rep"},{"issue":"21","key":"10.1016\/j.autrev.2026.104043_bb0405","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.89376","article-title":"Metabolic profiling indicates impaired pyruvate dehydrogenase function in myalgic encephalopathy\/chronic fatigue syndrome","volume":"1","author":"Fluge","year":"2016","journal-title":"JCI Insight"},{"issue":"16","key":"10.1016\/j.autrev.2026.104043_bb0410","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.149217","article-title":"A map of metabolic phenotypes in patients with myalgic encephalomyelitis\/chronic fatigue syndrome","volume":"6","author":"Hoel","year":"2021","journal-title":"JCI Insight"},{"key":"10.1016\/j.autrev.2026.104043_bb0415","article-title":"Charting the circulating proteome in ME\/CFS: cross system profiling and mechanistic insights","author":"Hoel","year":"2025","journal-title":"medRxiv"},{"issue":"13","key":"10.1016\/j.autrev.2026.104043_bb0420","doi-asserted-by":"crossref","DOI":"10.1172\/JCI144201","article-title":"Passive transfer of fibromyalgia symptoms from patients to mice","volume":"131","author":"Goebel","year":"2021","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2026.104043_bb0425","article-title":"Transfer of IgG from long COVID patients induces symptomology in mice","author":"Chen","year":"2024","journal-title":"bioRxiv"},{"key":"10.1016\/j.autrev.2026.104043_bb0430","series-title":"Demystifying Long Covid. International Conference","article-title":"Passive transfer of IgG from patients with long-COVID neurological symptoms induces tactile allodynia in Mice","author":"Mignolet","year":"2024"},{"issue":"6","key":"10.1016\/j.autrev.2026.104043_bb0435","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0179124","article-title":"Serological profiling of the EBV immune response in Chronic Fatigue Syndrome using a peptide microarray","volume":"12","author":"Loebel","year":"2017","journal-title":"PloS One"},{"key":"10.1016\/j.autrev.2026.104043_bb0440","article-title":"Revisiting IgG antibody reactivity to Epstein-Barr Virus in Myalgic encephalomyelitis\/chronic fatigue syndrome and its potential application to disease diagnosis","volume":"9","author":"Sep\u00falveda","year":"2022","journal-title":"Front Med (Lausanne)"},{"issue":"12","key":"10.1016\/j.autrev.2026.104043_bb0445","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/s41577-021-00543-w","article-title":"Autoantibodies in neurological disease","volume":"21","author":"Pr\u00fcss","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.autrev.2026.104043_bb0450","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.bbi.2020.12.022","article-title":"High frequency of cerebrospinal fluid autoantibodies in COVID-19 patients with neurological symptoms","volume":"93","author":"Franke","year":"2021","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.autrev.2026.104043_bb0455","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.bbi.2023.01.006","article-title":"Association of cerebrospinal fluid brain-binding autoantibodies with cognitive impairment in post-COVID-19 syndrome","volume":"109","author":"Franke","year":"2023","journal-title":"Brain Behav Immun"},{"issue":"6680","key":"10.1016\/j.autrev.2026.104043_bb0460","doi-asserted-by":"crossref","DOI":"10.1126\/science.adg7942","article-title":"Persistent complement dysregulation with signs of thromboinflammation in active Long Covid","volume":"383","author":"Cervia-Hasler","year":"2024","journal-title":"Science"},{"key":"10.1016\/j.autrev.2026.104043_bb0465","author":"National Library of Medicine (U.S.)"},{"issue":"1","key":"10.1016\/j.autrev.2026.104043_bb0470","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s42466-024-00311-w","article-title":"Randomized controlled double-blind trial of methylprednisolone versus placebo in patients with post-COVID-19 syndrome and cognitive deficits: study protocol of the post-corona-virus immune treatment (PoCoVIT) trial","volume":"6","author":"Franke","year":"2024","journal-title":"Neurol Res Pract"},{"key":"10.1016\/j.autrev.2026.104043_bb0475","author":"National Library of Medicine (U.S.)"},{"issue":"1","key":"10.1016\/j.autrev.2026.104043_bb0480","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1186\/s13063-024-07982-5","article-title":"IA-PACS-CFS: a double-blinded, randomized, sham-controlled, exploratory trial of immunoadsorption in patients with chronic fatigue syndrome (CFS) including patients with post-acute COVID-19 CFS (PACS-CFS)","volume":"25","author":"Pre\u00dfler","year":"2024","journal-title":"Trials"},{"key":"10.1016\/j.autrev.2026.104043_bb0485","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2023-076990","article-title":"Covid-19 vaccine effectiveness against post-covid-19 condition among 589 722 individuals in Sweden: population based cohort study","volume":"383","author":"Lundberg-Morris","year":"2023","journal-title":"BMJ"},{"key":"10.1016\/j.autrev.2026.104043_bb0490","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1404800","article-title":"High serum prevalence of autoreactive IgG antibodies against peripheral nerve structures in patients with neurological post-COVID-19 vaccination syndrome","volume":"15","author":"Arlt","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2026.104043_bb0495","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.bbi.2015.09.013","article-title":"Antibodies to \u03b2 adrenergic and muscarinic cholinergic receptors in patients with Chronic Fatigue Syndrome","volume":"52","author":"Loebel","year":"2016","journal-title":"Brain Behav Immun"},{"issue":"2","key":"10.1016\/j.autrev.2026.104043_bb0500","first-page":"225","article-title":"Autoantibodies against muscarinic cholinergic receptor in chronic fatigue syndrome","volume":"12","author":"Tanaka","year":"2003","journal-title":"Int J Mol Med"},{"issue":"6","key":"10.1016\/j.autrev.2026.104043_bb0505","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26062799","article-title":"An in-depth exploration of the autoantibody immune profile in ME\/CFS using novel antigen profiling techniques","volume":"26","author":"Germain","year":"2025","journal-title":"Int J Mol Sci"},{"issue":"3","key":"10.1016\/j.autrev.2026.104043_bb0510","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1002\/jmri.26247","article-title":"Brain abnormalities in myalgic encephalomyelitis\/chronic fatigue syndrome: Evaluation by diffusional kurtosis imaging and neurite orientation dispersion and density imaging","volume":"49","author":"Kimura","year":"2019","journal-title":"J Magn Reson Imaging"},{"issue":"6","key":"10.1016\/j.autrev.2026.104043_bb0515","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1111\/jon.12751","article-title":"Altered structural brain networks related to adrenergic\/muscarinic receptor autoantibodies in chronic fatigue syndrome","volume":"30","author":"Fujii","year":"2020","journal-title":"J Neuroimaging"},{"key":"10.1016\/j.autrev.2026.104043_bb0520","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.bbi.2021.03.023","article-title":"Skewing of the B cell receptor repertoire in myalgic encephalomyelitis\/chronic fatigue syndrome","volume":"95","author":"Sato","year":"2021","journal-title":"Brain Behav Immun"},{"issue":"3","key":"10.1016\/j.autrev.2026.104043_bb0525","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/cen3.12751","article-title":"Neuropilin-1 (NRP1): a new marker for pathogenic autoreactive T-helper cells in autoimmune disease","volume":"14","author":"Raveney","year":"2023","journal-title":"Clin Exp Neuroimmunol"},{"key":"10.1016\/j.autrev.2026.104043_bb0530","doi-asserted-by":"crossref","DOI":"10.1016\/j.lanepe.2024.101161","article-title":"Efficacy of repeated immunoadsorption in patients with post-COVID myalgic encephalomyelitis\/chronic fatigue syndrome and elevated \u03b22-adrenergic receptor autoantibodies: a prospective cohort study","volume":"49","author":"Stein","year":"2025","journal-title":"Lancet Region Health Europe"},{"issue":"5","key":"10.1016\/j.autrev.2026.104043_bb0535","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/0002-9343(90)90173-B","article-title":"A double-blind, placebo-controlled trial of intravenous immunoglobulin therapy in patients with chronic fatigue syndrome","volume":"89","author":"Lloyd","year":"1990","journal-title":"Am J Med"},{"issue":"1","key":"10.1016\/j.autrev.2026.104043_bb0540","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0002-9343(97)90045-0","article-title":"Intravenous immunoglobulin is ineffective in the treatment of patients with chronic fatigue syndrome","volume":"103","author":"Vollmer-Conna","year":"1997","journal-title":"Am J Med"},{"issue":"1","key":"10.1016\/j.autrev.2026.104043_bb0545","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0022-3956(96)00047-7","article-title":"Double-blind randomized controlled trial to assess the efficacy of intravenous gammaglobulin for the management of chronic fatigue syndrome in adolescents","volume":"31","author":"Rowe","year":"1997","journal-title":"J Psychiatr Res"},{"issue":"11","key":"10.1016\/j.autrev.2026.104043_bb0550","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10112420","article-title":"Tolerability and efficacy of s.c. IgG self-treatment in ME\/CFS patients with IgG\/IgG subclass deficiency: a proof-of-concept study","volume":"10","author":"Scheibenbogen","year":"2021","journal-title":"J Clin Med"},{"issue":"5","key":"10.1016\/j.autrev.2026.104043_bb0555","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1111\/joim.13592","article-title":"Intravenous immunoglobulins in the treatment of post-COVID: a case\u2013control study","volume":"293","author":"Hogeweg","year":"2023","journal-title":"J Intern Med"},{"key":"10.1016\/j.autrev.2026.104043_bb0560","author":"National Library of Medicine (U.S.)"},{"issue":"6","key":"10.1016\/j.autrev.2026.104043_bb0565","doi-asserted-by":"crossref","DOI":"10.3390\/biom10060958","article-title":"The hyperoxic-hypoxic paradox","volume":"10","author":"Hadanny","year":"2020","journal-title":"Biomolecules"},{"issue":"6","key":"10.1016\/j.autrev.2026.104043_bb0570","doi-asserted-by":"crossref","DOI":"10.14814\/phy2.14757","article-title":"Hyperbaric oxygen treatment is associated with a decrease in cytokine levels in patients with necrotizing soft-tissue infection","volume":"9","author":"Hedetoft","year":"2021","journal-title":"Physiol Rep"},{"issue":"12","key":"10.1016\/j.autrev.2026.104043_bb0575","doi-asserted-by":"crossref","DOI":"10.3390\/biom11121827","article-title":"Hyperbaric oxygen treatment: effects on mitochondrial function and oxidative stress","volume":"11","author":"Schottlender","year":"2021","journal-title":"Biomolecules"},{"issue":"2","key":"10.1016\/j.autrev.2026.104043_bb0580","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1039\/C6MB00600K","article-title":"Metabolic profiling of a myalgic encephalomyelitis\/chronic fatigue syndrome discovery cohort reveals disturbances in fatty acid and lipid metabolism","volume":"13","author":"Germain","year":"2017","journal-title":"Mol Biosyst"},{"issue":"24","key":"10.1016\/j.autrev.2026.104043_bb0585","doi-asserted-by":"crossref","first-page":"6528","DOI":"10.1093\/hmg\/ddu371","article-title":"Oxaloacetate activates brain mitochondrial biogenesis, enhances the insulin pathway, reduces inflammation and stimulates neurogenesis","volume":"23","author":"Wilkins","year":"2014","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.autrev.2026.104043_bb0590","series-title":"Oxaloacetate alters glucose metabolism in glioblastoma: 13c isotopomer study","article-title":"CBMT-49","volume":"21","author":"Ijare","year":"2019"},{"issue":"2","key":"10.1016\/j.autrev.2026.104043_bb0595","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1620\/tjem.96.127","article-title":"Studies on the anti-diabetic effect of sodium oxaloacetate","volume":"96","author":"Yoshikawa","year":"1968","journal-title":"Tohoku J Exp Med"},{"issue":"1","key":"10.1016\/j.autrev.2026.104043_bb0600","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1186\/s12967-022-03488-3","article-title":"Oxaloacetate treatment for mental and physical fatigue in Myalgic encephalomyelitis\/chronic fatigue syndrome (ME\/CFS) and Long-COVID fatigue patients: a non-randomized controlled clinical trial","volume":"20","author":"Cash","year":"2022","journal-title":"J Transl Med"},{"key":"10.1016\/j.autrev.2026.104043_bb0605","author":"National Library of Medicine (U.S.)"},{"key":"10.1016\/j.autrev.2026.104043_bb0610","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2024.1483876","article-title":"RESTORE ME: a RCT of oxaloacetate for improving fatigue in patients with myalgic encephalomyelitis\/chronic fatigue syndrome","volume":"15","author":"Cash","year":"2024","journal-title":"Front Neurol"},{"key":"10.1016\/j.autrev.2026.104043_bb0615","author":"National Library of Medicine (U.S.)"},{"key":"10.1016\/j.autrev.2026.104043_bb0620","article-title":"Pyridostigmine and low-dose naltrexone for ME\/CFS: study protocol for the life improvement trial (LIFT), a randomized, double-blind, placebo-controlled clinical trial","author":"Meadows","year":"2024","journal-title":"Research Square"},{"key":"10.1016\/j.autrev.2026.104043_bb0625","author":"National Library of Medicine (U.S.)"},{"key":"10.1016\/j.autrev.2026.104043_bb0630","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2017.00809","article-title":"Naltrexone inhibits IL-6 and TNF\u03b1 production in human immune cell subsets following stimulation with ligands for intracellular toll-like receptors","volume":"8","author":"Cant","year":"2017","journal-title":"Front Immunol"},{"issue":"4","key":"10.1016\/j.autrev.2026.104043_bb0635","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines11041087","article-title":"Efficacy of low-dose naltrexone and predictors of treatment success or discontinuation in fibromyalgia and other chronic pain conditions: a fourteen-year, enterprise-wide retrospective analysis","volume":"11","author":"Driver","year":"2023","journal-title":"Biomedicines"},{"issue":"4","key":"10.1016\/j.autrev.2026.104043_bb0640","first-page":"207","article-title":"Low-dose naltrexone in the treatment of myalgic encephalomyelitis\/chronic fatigue syndrome (ME\/CFS)","volume":"7","author":"Polo","year":"2019","journal-title":"Fatigue: Biomed Health Behav"},{"issue":"10","key":"10.1016\/j.autrev.2026.104043_bb0645","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.nmd.2022.09.002","article-title":"The effectiveness and side effects of pyridostigmine in the treatment of myasthenia gravis: a cross-sectional study","volume":"32","author":"Remijn-Nelissen","year":"2022","journal-title":"Neuromuscul Disord"},{"issue":"3","key":"10.1016\/j.autrev.2026.104043_bb0650","doi-asserted-by":"crossref","first-page":"315","DOI":"10.2174\/1570159X11311030006","article-title":"Acetylcholinesterase inhibitors: pharmacology and toxicology","volume":"11","author":"Colovi\u0107","year":"2013","journal-title":"Curr Neuropharmacol"},{"key":"10.1016\/j.autrev.2026.104043_bb0655","author":"National Library of Medicine (U.S.)"},{"issue":"268","key":"10.1016\/j.autrev.2026.104043_bb0660","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3009892","article-title":"mTOR inhibition improves immune function in the elderly","volume":"6","author":"Mannick","year":"2014","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.autrev.2026.104043_bb0665","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1310505","article-title":"Effects of low-dose rapamycin on lymphoid organs of mice prone and resistant to accelerated senescence","volume":"15","author":"Barros","year":"2024","journal-title":"Front Immunol"},{"issue":"754","key":"10.1016\/j.autrev.2026.104043_bb0670","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adk3295","article-title":"Tissue-based T cell activation and viral RNA persist for up to 2 years after SARS-CoV-2 infection","volume":"16","author":"Peluso","year":"2024","journal-title":"Sci Transl Med"},{"issue":"6","key":"10.1016\/j.autrev.2026.104043_bb0675","doi-asserted-by":"crossref","first-page":"e345","DOI":"10.1016\/S1473-3099(24)00211-1","article-title":"Plasma-based antigen persistence in the post-acute phase of COVID-19","volume":"24","author":"Peluso","year":"2024","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"10.1016\/j.autrev.2026.104043_bb0680","first-page":"95","article-title":"Effect of oral nirmatrelvir on long COVID symptoms: 4 cases and rationale for systematic studies","volume":"7","author":"Peluso","year":"2022","journal-title":"Pathog Immun"},{"key":"10.1016\/j.autrev.2026.104043_bb0685","author":"National Library of Medicine (U.S.)"},{"key":"10.1016\/j.autrev.2026.104043_bb0690","doi-asserted-by":"crossref","DOI":"10.1016\/S1473-3099(25)00073-8","article-title":"Nirmatrelvir-ritonavir versus placebo-ritonavir in individuals with long COVID in the USA (PAX LC): a double-blind, randomised, placebo-controlled, phase 2, decentralised trial","author":"Sawano","year":"2025","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.autrev.2026.104043_bb0695","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.ajem.2023.09.051","article-title":"Remission of severe forms of long COVID following monoclonal antibody (MCA) infusions: a report of signal index cases and call for targeted research","volume":"75","author":"Scheppke","year":"2024","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.autrev.2026.104043_bb0700","author":"National Library of Medicine (U.S.)"},{"issue":"9","key":"10.1016\/j.autrev.2026.104043_bb0705","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1001\/jamainternmed.2024.2007","article-title":"Nirmatrelvir-ritonavir and symptoms in adults with postacute sequelae of SARS-CoV-2 infection: the STOP-PASC randomized clinical trial","volume":"184","author":"Geng","year":"2024","journal-title":"JAMA Intern Med"},{"issue":"1","key":"10.1016\/j.autrev.2026.104043_bb0710","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1471-2377-9-28","article-title":"Clinical impact of B-cell depletion with the anti-CD20 antibody rituximab in chronic fatigue syndrome: a preliminary case series","volume":"9","author":"Fluge","year":"2009","journal-title":"BMC Neurol"},{"key":"10.1016\/j.autrev.2026.104043_bb0715","series-title":"B-cell depletion using the monoclonal anti-CD20 antibody rituximab in chronic fatigue syndrome. A double-blind, Placebo-controlled Study","author":"National Library of Medicine (U.S.)","year":"2009"},{"issue":"10","key":"10.1016\/j.autrev.2026.104043_bb0720","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0026358","article-title":"Benefit from B-lymphocyte depletion using the anti-CD20 antibody rituximab in chronic fatigue syndrome. A double-blind and placebo-controlled study","volume":"6","author":"Fluge","year":"2011","journal-title":"PloS One"},{"key":"10.1016\/j.autrev.2026.104043_bb0725","author":"National Library of Medicine (U.S.)"},{"issue":"7","key":"10.1016\/j.autrev.2026.104043_bb0730","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0129898","article-title":"B-lymphocyte depletion in Myalgic encephalopathy\/ chronic fatigue syndrome. An open-label phase II study with rituximab maintenance treatment","volume":"10","author":"Fluge","year":"2015","journal-title":"PloS One"},{"issue":"9","key":"10.1016\/j.autrev.2026.104043_bb0735","doi-asserted-by":"crossref","first-page":"585","DOI":"10.7326\/M18-1451","article-title":"B-lymphocyte depletion in patients with Myalgic encephalomyelitis\/chronic fatigue syndrome: a randomized, double-blind, placebo-controlled trial","volume":"170","author":"Fluge","year":"2019","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.autrev.2026.104043_bb0740","author":"National Library of Medicine (U.S.)"},{"key":"10.1016\/j.autrev.2026.104043_bb0745","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2020.00162","article-title":"Intravenous cyclophosphamide in Myalgic encephalomyelitis\/chronic fatigue syndrome. An open-label phase II study","volume":"7","author":"Rekeland","year":"2020","journal-title":"Front Med"},{"key":"10.1016\/j.autrev.2026.104043_bb0750","author":"National Library of Medicine (U.S.)"},{"issue":"7","key":"10.1016\/j.autrev.2026.104043_bb0755","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0307484","article-title":"Six-year follow-up of participants in two clinical trials of rituximab or cyclophosphamide in Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome","volume":"19","author":"Rekeland","year":"2024","journal-title":"PloS One"},{"issue":"14","key":"10.1016\/j.autrev.2026.104043_bb0760","doi-asserted-by":"crossref","DOI":"10.1172\/JCI150377","article-title":"Pathomechanisms and possible interventions in Myalgic encephalomyelitis\/chronic fatigue syndrome (ME\/CFS)","volume":"131","author":"Fluge","year":"2021","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2026.104043_bb0765","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2025.1607353","article-title":"Plasma cell targeting with the anti-CD38 antibody daratumumab in myalgic encephalomyelitis\/chronic fatigue syndrome \u2014 a clinical pilot study","volume":"12","author":"Fluge","year":"2025","journal-title":"Front Med"},{"key":"10.1016\/j.autrev.2026.104043_bb0770","author":"European Medicines Agency (EMA)"},{"key":"10.1016\/j.autrev.2026.104043_bb0775","author":"European Medicines Agency (EMA)"},{"key":"10.1016\/j.autrev.2026.104043_bb0780","author":"National Library of Medicine (U.S.)"},{"issue":"3","key":"10.1016\/j.autrev.2026.104043_bb0785","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.1440-1819.2009.01954.x","article-title":"A two-year follow-up study of chronic fatigue syndrome comorbid with psychiatric disorders","volume":"63","author":"Matsuda","year":"2009","journal-title":"Psychiatry Clin Neurosci"},{"issue":"2","key":"10.1016\/j.autrev.2026.104043_bb0790","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.chom.2023.01.004","article-title":"Deficient butyrate-producing capacity in the gut microbiome is associated with bacterial network disturbances and fatigue symptoms in ME\/CFS","volume":"31","author":"Guo","year":"2023","journal-title":"Cell Host Microbe"},{"issue":"8","key":"10.1016\/j.autrev.2026.104043_bb0795","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1007\/s00406-023-01724-5","article-title":"All eyes on PCS: analysis of the retinal microvasculature in patients with post-COVID syndrome-study protocol of a 1 year prospective case-control study","volume":"274","author":"Kuchler","year":"2024","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"10.1016\/j.autrev.2026.104043_bb0800","author":"Fehrer"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997226000571?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997226000571?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T15:19:48Z","timestamp":1777130388000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997226000571"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":160,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S1568997226000571"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2026.104043","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Expert perspectives on Myalgic encephalomyelitis\/chronic fatigue syndrome \u2013 Insights from the 3rd International Conference of the Charit\u00e9 Fatigue Center","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2026.104043","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"104043"}}